DDB2 decides cell fate following DNA damage

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 26, 2009, Pages 10690-10695

  Stoyanova, Tanya ^a   Roy, Nilotpal ^a   Kopanja, Dragana ^a   Bagchi, Srilata ^a   Raychaudhuri, Pradip ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptosis; Cell cycle; DDB2; Mdm2; p21

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DAMAGED DNA BINDING PROTEIN 2; DNA BINDING PROTEIN; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP E PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL FATE; CONTROLLED STUDY; DNA DAMAGE; EXCISION REPAIR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ACLARUBICIN; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELLS, CULTURED; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FIBROBLASTS; FLOW CYTOMETRY; HELA CELLS; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 67649774566     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0812254106     Document Type: Article

References (38)

1. Nichols AF, Itoh T, Graham JA, Liu W, Yamaizumi M, et al. (2000) Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation. J Biol Chem 275:21422-21428. (Pubitemid 30481844)
2. Nichols AF, Ong P, Linn S (1996) Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype. J Biol Chem 271:24317-24320. (Pubitemid 26333157)
3. Itoh T, Cado D, Kamide R, Linn S (2004) DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. Proc Natl Acad Sci USA 101:2052-2057. (Pubitemid 38229013)
4. Yoon T, Chakrabortty A, Franks R, Valli T, Kiyokawa H, et al. (2005) Tumor-prone phenotype of the DDB2-deficient mice. Oncogene 24:469-478.
5. Alekseev S, Kool H, Rebel H, Fousteri M, Moser J, et al. (2005) Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation. Cancer Res 65:10298-10306. (Pubitemid 41743722)
6. Kapetanaki MG, Guerrero-Santoro J, Bisi DC, Hsieh CL, Rapic-Otrin V, et al. (2006) The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci USA 103:2588-2593. (Pubitemid 43306593)
7. Wang H, Zhai L, Xu J, Joo HY, Jackson S, et al. (2006) Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell 22:383-394. (Pubitemid 44308132)
8. Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, et al. (2005) UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 121:387-400. (Pubitemid 40692299)
9. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Praetorius-Ibba M, et al. (2006) Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC. J Biol Chem 281:13404-13411. (Pubitemid 43855252)
10. Rapic-Otrin V, McLenigan MP, Bisi DC, Gonzalez M, Levine AS (2002) Sequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation. Nucleic Acids Res 30:2588-2598. (Pubitemid 34619012)
11. Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P (2008) The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol Cell Biol 28:177-187.
12. Cooper MP, Balajee AS, Bohr VA (1999) The C-terminal domain of p21 inhibits nucleotide excision repair in vitro and in vivo. Mol Biol Cell 10:2119-2129. (Pubitemid 29343123)
13. Pan ZQ, Reardon JT, Li L, Flores-Rozas H, Legerski R, et al. (1995) Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol Chem 270:22008-22016.
14. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
15. Tan T, Chu G (2002) p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 22:3247-3254. (Pubitemid 34453967)
16. Nichols AF, Itoh T, Zolezzi F, Hutsell S, Linn S (2003) Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements. Nucleic Acids Res 31:562-569. (Pubitemid 36175945)
17. Huang S, Shu L, Dilling MB, Easton J, Harwood FC, et al. (2003) Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 11:1491-1501. (Pubitemid 36776536)
18. Zhan J, Easton JB, Huang S, Mishra A, Xiao L, et al. (2007) Negative regulation of ASK1 by p21Cip1 involves a small domain that includes Serine 98 that is phosphorylated by ASK1 in vivo. Mol Cell Biol 27:3530-3541. (Pubitemid 46685227)
19. Tian H, Wittmack EK, Jorgensen TJ (2000) p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res 60:679-684. (Pubitemid 30094567)
20. Seoane J, Le HV, Massague J (2002) Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419:729-734. (Pubitemid 35177959)
21. Itoh T, O'Shea C, Linn S (2003) Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: Mutual regulatory interactions between p48(DDB2) and p53. Mol Cell Biol 23:7540-7553. (Pubitemid 37271455)
22. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR (2005) PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309:1732-1735. (Pubitemid 41285944)
23. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365.
24. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, et al. (2003) p53 Has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590. (Pubitemid 36385115)
25. Cang Y, Zhang J, Nicholas SA, Kim AL, Zhou P, et al. (2007) DDB1 is essential for genomic stability in developing epidermis. Proc Natl Acad Sci USA 104:2733-2737. (Pubitemid 46327948)
26. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, et al. (2008) PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 22:2496-2506.
27. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR (1997) Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245-7250. (Pubitemid 27345300)
28. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR (1995) E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 69:2491-2500.
29. Sohn D, Essmann F, Schulze-Osthoff K, Janicke RU (2006) p21 Blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation. Cancer Res 66:11254-11262. (Pubitemid 46009954)
30. Giono LE, Manfredi JJ (2007) Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest. Mol Cell Biol 27:4166-4178. (Pubitemid 47011012)
31. Amador V, Ge S, Santamaria PG, Guardavaccaro D, Pagano M (2007) APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell 27:462-473. (Pubitemid 47126938)
32. Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM (2007) Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 26:843-852. (Pubitemid 46921008)
33. Jin Y, Zeng SX, Sun XX, Lee H, Blattner C, et al. (2008) MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, Mdm2. Mol Cell Biol 28:1218-1229. (Pubitemid 351214125)
34. Li X, Amazit L, Long W, Lonard DM, Monaco J J, et al. (2007) Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 26:831-842. (Pubitemid 46921009)
35. Brown DR, Thomas CA, Deb SP (1998) The human oncoprotein Mdm2 arrests the cell cycle: Elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J 17:2513-2525. (Pubitemid 28221187)
36. Dang J, Kuo ML, Eischen CM, Stepanova L, Sherr C J, et al. (2002) The RING domain of Mdm2 can inhibit cell proliferation. Cancer Res 62:1222-1230. (Pubitemid 34160312)
37. Reef S, Zalckvar E, Shifman O, Bialik S, Sabanay H, et al. (2006) A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol Cell 22:463-475.
38. Major M, Lepe R, Costa R. (2004) Forkhead Box M1B transcriptional actvity requires binding of CDK-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol Cell Biol 24:2649-2661. (Pubitemid 38381258)